INTRODUCTION AND OBJECTIVES: Embyrologically, gonads are derived from mesonephrons while kidneys are derived from metanephrons. Our previous study demonstrated a positive association between kidney injury molecule-1 (KIM-1) staining and renal cell (papillary/clear cell type), and ovarian carcinoma (clear cell). The preliminary data also revealed positive KIM-1 staining in the tubules of mesonephrons, raising the possibility of KIM-1 expression in various testicular tumors. This study was to investigate whether KIM-1 and CD133 (a progenitor cell marker known to be positive in some renal cell carcinoma) expressions can help predict or differentiate various germ cell neoplasms of testis.
METHODS: A total of 29 cases of seminoma and 31 cases of mixed germ cell neoplasms were identified. Tumors were sectioned and immunohistochemically stained for KIM-1 (AKG7 monoclonal KIM-1 antibody from JV Bonventre, BWH, Boston, at dilution 1:10) and CD133 (AC133 monoclonal antibody, Miltenyi Biotec, at 1:100 dilution). The membranous staining of each marker was graded 0 to 3+ and the percent of expressive distribution was recorded.
RESULTS: KIM-1 was found to stain 77.4% (24/31, intensity at 1 to 3+, and distribution ranging from 1% to 90%) of mixed germ cell neoplasms (predominantly embryonal and yolk sac components), whereas there was no KIM-1 expression in benign seminiferous tubules, mature teratoma, classic seminoma and Leydig cell tumor. Scattered and weak CD133 staining was seen in seminoma and mixed germ cell tumors (10% and 16% respectively) and absent in benign tissue, mature teratoma and Leydig cell tumor.
CONCLUSIONS: Our data suggest that KIM-1 expression can be used to differentiate mixed germ cell neoplasms from pure seminomas (negative for KIM-1 staining). CD133 appears to be not as useful in differentiating various testicular tumors.
Source of Funding: None

MP80-19 TREATMENT TRENDS AND OUTCOMES FOR LYMPH NODE POSITIVE PENILE CANCER PATIENTS
Shreyas Joshi*, Handorf Elizabeth, Andres Correa, Michael Haifler, Benjamin Ristau, Robert Uzzo, Richard Greenberg, David Chen, Rosalia Viterbo, Alexander Kutikov, Marc Smaldone, Daniel Geynisman, Philadelphia, PA INTRODUCTION AND OBJECTIVES: Penile cancer is an uncommon disease with little level I evidence to guide therapy. The NCCN guidelines advocate a lymph node dissection (LND) with consideration of perioperative chemotherapy (CT) for all lymph node positive (LN+) penile cancer (PC) pts. Using a large national cancer registry, we assessed temporal trends in utilization of CT for LN+M0 PC, and evaluated outcomes between those who did (LND+) and did not (LND-) receive a LND and/or chemotherapy (CT+ vs. CT-).
METHODS: The National Cancer Database (NCDB) was queried for all non-metastatic PC patients with LN+ squamous cell carcinoma of the penis from 2004-2014. Temporal trends were assessed using Cochran-Armitage tests. Adjusting for patient, clinical, and tumor characteristics, multivariable logistic models were used to examine the association between clinicopathologic characteristics and receipt of CT. Kaplan Meier analyses with log-rank tests and multivariable Cox regressions were used to analyze overall survival (OS).
RESULTS: Of 1123 pts identified, 750 (67%) underwent a LND. Receipt of chemotherapy was similar in both LND+ (40%) and LND-(42%) pts (p¼0.53). From 2004-2014, the overall utilization of systemic therapy significantly increased (38% vs. 48%. p¼0.0009). However, only 53% of N3 patients received CT (N1 31%, N2 40%). Following adjustment, older patients (76 + years: OR 0.34 [CI 0.19-0.59], p¼0.0002) were less likely to receive CT, while N2 (OR 1.62 [CI 1.16-2.27], p¼0.005) and N3 (OR 2.32 [CI 1.67-3.22], p<0.0001) pts were more likely to receive CT. High volume centers ( 4 cases of PC/year; 29% of all LN+ cases) delivered less CT (OR 0.69 [CI 0.48-1.00], p¼0.047). OS varied from 14.9 mo in the LND-/CT-group to 42.6 mo in the LND+/CT+ group. On multivariable analysis, receipt of CT was not associated with OS (HR 0.95 [CI 0.77-1.19], p¼0.67).
CONCLUSIONS: In hospitals reporting to the NCDB, only 67% of LN+ PC pts receive a LND. While CT utilization has increased since 2004, rates remain low, even for N3 pts for whom the NCCN clearly recommends systemic therapy. Surprisingly, high volume centers were less likely to deliver CT for LN+ patients. Receipt of CT does not appear to affect OS, which likely reflects the aggressive natural history of PC. Nonetheless, these data highlight opportunities to improve adherence to guideline-recommended care.
Source of Funding: none
MP80-20 COMPLICATIONS AND ADJUNCTIVE SURGICAL PROCEDURES IN POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND) TO DEFINE A TERTIAL REFERRAL CENTER
Achim Lusch*, Laura Gerbaulet, Christian Winter, Peter Albers, Duesseldorf, Germany INTRODUCTION AND OBJECTIVES: Post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) is standard of care for patients with advanced germ cell tumors and residual disease. Due to the invasiveness and complexity of the disease additional surgical procedures may be necessary. This analysis aims to quantify the additional procedures in order to define the necessity for other surgical specialties on an ad hoc basis.
METHODS: We performed a retrospective analysis of 431 PC-RPLNDs in 382 patients for intra-and postoperative complications as well as additional surgical procedures. Complications were classified by Clavien-Dindo grading.
RESULTS: 431 RPLNDs with 383 PC-RPLNDs were performed between 2008 und 2016 in a single center. Mean patient age was 35 years with a mean tumor size of 6 cm. PC-RPLND was performed unilaterally in 176 patients (40.8%) and bilaterally in 253 patients (58.7%). Mean OR time was 217 minutes (range 60-510 min) with a mean intra-operative blood loss of 1026 cc (range 0-15000). 128 patients (29.7%) received blood transfusions. A significant vascular intervention during the operation occurred in 78 patients (18.1%) e vena cava procedures including resection and cavotomie were necessary in 24 patients (7.2%) and aortic replacement in 7 patients (1.8%). Nephrectomy was performed in 41 cases (9.7%), 32 patients received partial liver resection (7.4%) and 14 patients needed vertebral resection (3.2%). During the postoperative course 24 patients (4.6%) showed a lymphocele. Complications by Clavien Grading: (including post OP complications) Grade I: 84 (19.4%) (inclusive post OP hematoma and lymphocele), Grade II: 128 (29.6%) (incl. blood transfusion); Grade III: 9 (2.1%); Grade III b: 9 (2.1%); Grade IV a: 4 (0.9%); Grade V: 1 (0.2%).
CONCLUSIONS: PC-RPLND in testis cancer patients is a demanding operation which frequently requires a multivisceral surgical approach in about 30% of cases. Adjunctive surgical procedures which require other surgical specialties such as vascular interventions including cava resection, aortic grafting or extensive liver and vertrebral resections may be ad hoc necessary. Consequently tertial referral centers are defined to provide ad hoc surgical specialty service and this type of surgery should not be perfomed outside of these centers due to the high frequency of a multivisceral approach.
